June 1, 2025Open Access

Advanced Basal Cell Carcinoma: A Narrative Review on Current Systemic Treatments and the Neoadjuvant Approach

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Advanced BCC treatment is challenging, and the neoadjuvant approach followed by surgery is expected to reduce surgical complexity, increase tissue preservation, and improve patients' satisfaction.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Paradisi et al. (Sun,) studied this question.

synapsesocial.com/papers/6a0043726018b8d0892db09a https://doi.org/https://doi.org/10.3390/jpm15060226

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Neoadjuvant Checkpoint Immunotherapy and Melanoma: The Time Is Now2023 · 87 citations
2Complete Remission of Basal Cell Carcinoma Following Treatment With Cemiplimab After 2 Years2021 · 10 citations
3Neoadjuvant anti-PD-1-based immunotherapy: evolving a new standard of care2025 · 14 citations
4Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study2019 · 15 citations
5Preoperative evaluation of high-risk basal cell carcinoma with line-field confocal optical coherence tomography (LC-OCT) reduces Mohs micrographic surgery stage number: A case-control study2023 · 19 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo